IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes

  • Authors:
    • Bartlomiej E. Krazinski
    • Anna E. Kowalczyk
    • Agnieszka Sliwinska‑Jewsiewicka
    • Jedrzej Grzegrzolka
    • Janusz Godlewski
    • Przemyslaw Kwiatkowski
    • Piotr Dziegiel
    • Zbigniew Kmiec
    • Jolanta Kiewisz
  • View Affiliations

  • Published online on: November 19, 2018     https://doi.org/10.3892/or.2018.6872
  • Pages: 1189-1197
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Inhibitor of nuclear factor kappa B kinase subunit B (IKBKB or IKKβ) is a key activator of the nuclear factor κB transcription factor pathway. Increased expression and/or aberrant activity of IKBKB have been observed in various types of human cancer. Three independent techniques, reverse transcription‑quantitative polymerase chain reaction, western blotting and immunohistochemistry, were used to demonstrate that IKBKB expression is decreased in clear cell renal cell carcinoma (ccRCC). Notably, the patients with upregulated IKBKB protein expression were characterized by higher nuclear grade tumors and significantly shorter survival. The findings indicate that IKBKB protein may be of clinical relevance in ccRCC, serving as a marker of poor prognosis and as potential target for adjuvant chemotherapies. Further studies are required to validate the prognostic and predictive value of IKBKB.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 41 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Krazinski BE, Kowalczyk AE, Sliwinska‑Jewsiewicka A, Grzegrzolka J, Godlewski J, Kwiatkowski P, Dziegiel P, Kmiec Z and Kiewisz J: IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes. Oncol Rep 41: 1189-1197, 2019
APA
Krazinski, B.E., Kowalczyk, A.E., Sliwinska‑Jewsiewicka, A., Grzegrzolka, J., Godlewski, J., Kwiatkowski, P. ... Kiewisz, J. (2019). IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes. Oncology Reports, 41, 1189-1197. https://doi.org/10.3892/or.2018.6872
MLA
Krazinski, B. E., Kowalczyk, A. E., Sliwinska‑Jewsiewicka, A., Grzegrzolka, J., Godlewski, J., Kwiatkowski, P., Dziegiel, P., Kmiec, Z., Kiewisz, J."IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes". Oncology Reports 41.2 (2019): 1189-1197.
Chicago
Krazinski, B. E., Kowalczyk, A. E., Sliwinska‑Jewsiewicka, A., Grzegrzolka, J., Godlewski, J., Kwiatkowski, P., Dziegiel, P., Kmiec, Z., Kiewisz, J."IKBKB expression in clear cell renal cell carcinoma is associated with tumor grade and patient outcomes". Oncology Reports 41, no. 2 (2019): 1189-1197. https://doi.org/10.3892/or.2018.6872